Human Albumin Market will Revenue to Cross 1098.75 in 2020 to 2026 Research by Business Opportunities, Top Companies report covers, Market-specific challenges, consumption by Regional data
/
Date11 Aug 2020
Email Print Friendly Share Pune, Aug. 11, 2020 (GLOBE NEWSWIRE) — Global “Human Albumin Market ” analysis 2020 covers the entire supply chain, focusing on... Read More →
New study published in the Journal of the National Cancer Institute concludes that Epi proColon® is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening
/
Date10 Aug 2020
Email Print Friendly Share Under the primary base case analysis, annual mSEPT9 screening resulted in more Quality-adjusted-life-years gained (QALYG), CRC cases averted and CRC deaths averted... Read More →
Lung cancer researchers present new clinical trial data at International Association for the Study of Lung Cancer World Conference on Lung Cancer Virtual Presidential Symposium
/
Date09 Aug 2020
Email Print Friendly Share DENVER, Aug. 08, 2020 (GLOBE NEWSWIRE) — The combination of first-line nivolumab and ipilimumab demonstrated an improvement of overall survival for... Read More →
SeaSpine Reports Granting of Inducement Awards
/
Date08 Aug 2020
Email Print Friendly Share CARLSBAD, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical... Read More →
ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 – 12, 2020
/
Date07 Aug 2020
Email Print Friendly Share Geneva, Switzerland and Boston, MA – August 7, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and... Read More →
ObsEva Announces Second Quarter 2020 Financial Results and Business Update
/
Date06 Aug 2020
Email Print Friendly Share Primary endpoint successfully met in Phase 3 PRIMROSE 1 trial of linzagolix for the treatment of heavy menstrual bleeding due... Read More →
Obésité : nouvelles lignes directrices de pratique clinique canadienne
/
Date05 Aug 2020
Email Print Friendly Share MONTRÉAL, 04 août 2020 (GLOBE NEWSWIRE) — En réaction aux nouvelles lignes directrices de pratique clinique en lien avec l’obésité, dévoilées... Read More →
Tiziana Life Sciences Announces an Expedited Clinical Development Plan for Its Anti-Interleukin-6-Receptor, a Fully Human Monoclonal Antibody, for the Treatment of COVID-19 Patients
/
Date04 Aug 2020
Email Print Friendly Share Recently signed agreements with four contract research organizations (“CROs”) to initiate GMP manufacturing, develop inhalation technology, conduct inhalation safety toxicity study... Read More →
Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
/
Date03 Aug 2020
Email Print Friendly Share SAN DIEGO, July 31, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics Holdings Inc. (the “Company”, Nasdaq: ARCT), a leading clinical-stage messenger RNA... Read More →
Naropa Community Counseling Offers Community Coronavirus-Specific Support
/
Date02 Aug 2020
Email Print Friendly Share Boulder, CO, July 31, 2020 (GLOBE NEWSWIRE) — The COVID-19 virus has created a devastating impact on life as we know... Read More →